Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources
News and Community
About us

GlaxoSmithKline Australia Pty Ltd

Regulatory activities for this sponsor.

Loading...

Cancellation by sponsor (234) Cancellation by sponsor (234)
ARTG (112) ARTG (112)
Australian Public Assessment Report (AusPAR) (41)
Prescription medicine registration (19)
Designation or determination (5) Designation or determination (5)
Prescription medicine decision summary (3)
Prescription medicine evaluation (3) Prescription medicine evaluation (3)
Face mask cancellation (1) Face mask cancellation (1)

2025 (10) 2025 (10)
2024 (15) 2024 (15)
2023 (18) 2023 (18)
2022 (61) 2022 (61)
2021 (12) 2021 (12)
2020 (59) 2020 (59)
2019 (31) 2019 (31)
2018 (27) 2018 (27)
2017 (24) 2017 (24)
2016 (11) 2016 (11)
2015 (51) 2015 (51)
2014 (21) 2014 (21)
2013 (9) 2013 (9)
2012 (6) 2012 (6)
2011 (4) 2011 (4)
2010 (7) 2010 (7)
2009 (3) 2009 (3)
2008 (6) 2008 (6)
2007 (6) 2007 (6)
2006 (3) 2006 (3)
2005 (4) 2005 (4)
2004 (1) 2004 (1)
2003 (3) 2003 (3)
2002 (1) 2002 (1)
2001 (1) 2001 (1)
2000 (3) 2000 (3)
1999 (4) 1999 (4)
1998 (5) 1998 (5)
1997 (4) 1997 (4)
1995 (1) 1995 (1)
1991 (6) 1991 (6)

Search

Sponsor content

418 result(s) found, displaying 411 to 418

SEREVENT ACCUHALER salmeterol 50 micrograms (as xinafoate) powder for inhalation blister pack (53775)

31 October 1995

ARTG

Australian Register of Therapeutic Goods (ARTG) information for SEREVENT ACCUHALER salmeterol 50 micrograms (as xinafoate) powder for inhalation blister pack.
BACTROBAN mupirocin 20mg/g ointment tube (11145)

14 August 1991

ARTG

Australian Register of Therapeutic Goods (ARTG) information for BACTROBAN mupirocin 20mg/g ointment tube.
BACTROBAN mupirocin 2% nasal ointment tube (11199)

14 August 1991

ARTG

Australian Register of Therapeutic Goods (ARTG) information for BACTROBAN mupirocin 2% nasal ointment tube.
VENTOLIN NEBULES salbutamol 2.5mg/2.5mL (as sulfate) inhalation solution ampoule (12533)

13 August 1991

ARTG

Australian Register of Therapeutic Goods (ARTG) information for VENTOLIN NEBULES salbutamol 2.5mg/2.5mL (as sulfate) inhalation solution ampoule.
VENTOLIN NEBULES salbutamol 5mg/2.5mL (as sulfate) inhalation solution ampoule (12534)

13 August 1991

ARTG

Australian Register of Therapeutic Goods (ARTG) information for VENTOLIN NEBULES salbutamol 5mg/2.5mL (as sulfate) inhalation solution ampoule.
VENTOLIN OBSTETRIC salbutamol 5mg/5mL (as sulfate) injection ampoule (12528)

13 August 1991

ARTG

Australian Register of Therapeutic Goods (ARTG) information for VENTOLIN OBSTETRIC salbutamol 5mg/5mL (as sulfate) injection ampoule.
VENTOLIN salbutamol 500microgram/1mL (as sulfate) injection ampoule (12527)

13 August 1991

ARTG

Australian Register of Therapeutic Goods (ARTG) information for VENTOLIN salbutamol 500microgram/1mL (as sulfate) injection ampoule.
Mask, <specify> (GlaxoSmithKline Australia Pty Ltd)

Face mask cancellation

Sponsor-initiated cancellation

Pages

First page
Previous page
…
Page 34
Page 35
Page 36
Page 37
Page 38
Page 39
Page 40
Page 41
Current page 42

Is there anything wrong with this page?

Help us improve this page

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control - external site
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook - external site
(formerly Twitter) - external site
Youtube - external site
Instagram - external site
LinkedIn - external site

Help us improve

We are always looking for ways to improve our website.

Provide feedback - external site

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.

GlaxoSmithKline Australia Pty Ltd

Type

Date

Help us improve this page